FinTechFunding

Protillion Biosciences: Raises $18M in Series A Financing

Protillion Biosciences Raises $18M in Series A Financing

  • Protillion Biosciences, a Burlingame, CA-based biotech company, raised $18M in Series A funding
  • The round was led by ARCH Venture Partners and Illumina Ventures
  • The company intends to use the funds to scale its hardware infrastructure and development teams
  • ProtillionBiosciences is a Stanford University spinout commercializing technology for therapeutic antibody and binder discovery
  • The company’s platform enables its commercial drug discovery partners to perform quantitative analysis on complete protein libraries, producing actionable insights in days
Previous article
ImagenAI: Raises $30M in Funding
Next article
Taina: Raises Funding Round 
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Italy Fines Revolut €1.15M for Regulatory Violations

Revolut faces penalties due to non-compliance with Italian financial regulations.Highlights: Italy fines Revolut €1.15 million for regulatory breaches.The...
FinTech

DeFi Platform Drift Suspends Withdrawals After Crypto Hack

Drift takes precautionary measures following security breach affecting user funds.Highlights: Drift has suspended all deposits and withdrawals after...
FinTech

Cross River Bank Raises $50 Million to Accelerate Growth

The funding will enhance Cross River Bank's financial technology services.Highlights: Cross River Bank has raised $50 million in...
FinTech

Kulipa Secures $62M to Enhance Stablecoin Card Issuing Infrastructure

Funding aims to strengthen cryptocurrency card services in the growing fintech market.Highlights: Kulipa raises $62M to enhance its...